Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma Meeting Abstract
| Authors: | Duvic, M.; Horwitz, S. M.; Kim, Y. H.; Zinzani, P. L.; Bhat, G.; Sharma, P.; Yancik, S. |
| Abstract Title: | Results from a phase 1/2, open-label, dose-finding study of pralatrexate and oral bexarotene in patients with relapsed/refractory cutaneous T-cell lymphoma |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368020102189 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.2677.2677 |
| Notes: | Meeting Abstract: 2677 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
